openPR Logo
Press release

Car T Cell Therapy Market is Expected to Exhibit of 118,680.68 Million Massive Growth at 43.20% over Forecast Period 2024-2032

05-08-2024 02:13 PM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Car T Cell Therapy Market

Car T Cell Therapy Market

๐€๐œ๐œ๐จ๐ซ๐๐ข๐ง๐  ๐ญ๐จ ๐ญ๐ก๐ž ๐ซ๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ, ๐ญ๐ก๐ž ๐ ๐ฅ๐จ๐›๐š๐ฅ ๐œ๐š๐ซ-๐ญ ๐œ๐ž๐ฅ๐ฅ ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ฒ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ฐ๐š๐ฌ ๐ฏ๐š๐ฅ๐ฎ๐ž๐ ๐š๐ญ ๐”๐’๐ƒ ๐Ÿ’๐Ÿ”๐Ÿ•๐Ÿ’.๐Ÿ‘ ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ‘ ๐š๐ง๐ ๐ข๐ฌ ๐ž๐ฑ๐ฉ๐ž๐œ๐ญ๐ž๐ ๐ญ๐จ ๐ซ๐ž๐š๐œ๐ก ๐”๐’๐ƒ ๐Ÿ๐Ÿ๐Ÿ–,๐Ÿ”๐Ÿ–๐ŸŽ.๐Ÿ”๐Ÿ– ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ, ๐ญ๐จ ๐ ๐ซ๐จ๐ฐ ๐š๐ญ ๐š ๐‚๐€๐†๐‘ ๐จ๐Ÿ ๐Ÿ’๐Ÿ‘.๐Ÿ๐ŸŽ% ๐๐ฎ๐ซ๐ข๐ง๐  ๐ญ๐ก๐ž ๐Ÿ๐จ๐ซ๐ž๐œ๐š๐ฌ๐ญ ๐ฉ๐ž๐ซ๐ข๐จ๐.

Chimeric antigen receptor (CAR) T-cell therapy is one of the newest and most promising treatment options for blood cancer. As a form of cancer immunotherapy, CART-T cell therapy involves the use of immune cells known as T cells. These cells are genetically modified in a lab to enable them to locate and destroy cancer cells more effectively. The therapy involves several steps and takes a few weeks to complete. It starts with the collection of T cells by drawing blood from a vein in the patient's arm.

๐‚๐ฅ๐ข๐œ๐ค ๐ญ๐จ ๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐ƒ๐… ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐š๐ง๐ ๐ƒ๐ซ๐ข๐ฏ๐ž ๐ˆ๐ฆ๐ฉ๐š๐œ๐ญ๐Ÿ๐ฎ๐ฅ ๐ƒ๐ž๐œ๐ข๐ฌ๐ข๐จ๐ง๐ฌ:

๐Š๐ž๐ฒ ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐๐š๐ซ๐ญ๐ข๐œ๐ข๐ฉ๐š๐ง๐ญ๐ฌ

The CAR-T cell therapy market is fragmented in nature. The top industry players are adopting strategic developments to garner a larger revenue share of the market. Among the key industry participants include:

โ€ข Amgen Inc. (US)
โ€ข Bellicum Pharmaceuticals Inc. (US)
โ€ข Bluebird Bio (US)
โ€ข Caribou Biosciences Inc. (US)
โ€ข Celgene Corporation
โ€ข Cellectis
โ€ข Celyad
โ€ข Gilead Sciences Inc.
โ€ข Intellia Therapeutics
โ€ข Johnson & Johnson
โ€ข Merck KGaA
โ€ข Nanjing Legend Biotechnology Co Ltd.
โ€ข Noile-Immune Biotech
โ€ข Novartis International AG
โ€ข Pfizer Inc.
โ€ข Sangamo Therapeutics Inc.
โ€ข Servier Laboratories.

These cells are then engineered in a lab by adding a manufactured CAR. After this, the cells are infused back into the body. Once the cancer is in remission, the healthcare provider may recommend other treatments, like a stem cell transplant.

๐†๐ž๐ญ ๐€๐ก๐ž๐š๐ ๐ฐ๐ข๐ญ๐ก ๐ƒ๐ž๐ญ๐š๐ข๐ฅ๐ž๐ ๐‘๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ:

๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ฅ ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ

๐‚๐€๐‘-๐“ ๐‚๐ž๐ฅ๐ฅ ๐“๐ก๐ž๐ซ๐š๐ฉ๐ฒ, ๐“๐š๐ซ๐ ๐ž๐ญ ๐€๐ง๐ญ๐ข๐ ๐ž๐ง ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค (๐‘๐ž๐ฏ๐ž๐ง๐ฎ๐ž - ๐”๐’๐ƒ ๐Œ๐ข๐ฅ๐ฅ๐ข๐จ๐ง, ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ— - ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ)
โ€ข CD19/CD22
โ€ข BCMA (B-Cell Maturation Antigen)
โ€ข Others (MUC16, L1CAM, ROR1, EGFRvIII, PSCA, NKR-2, IL13Ra2, LewisY)

๐‚๐€๐‘-๐“ ๐‚๐ž๐ฅ๐ฅ ๐“๐ก๐ž๐ซ๐š๐ฉ๐ฒ, ๐ˆ๐ง๐๐ข๐œ๐š๐ญ๐ข๐จ๐ง ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค (๐‘๐ž๐ฏ๐ž๐ง๐ฎ๐ž - ๐”๐’๐ƒ ๐Œ๐ข๐ฅ๐ฅ๐ข๐จ๐ง, ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ— - ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ)
โ€ข ALL
โ€ข CLL
โ€ข MM
โ€ข FL
โ€ข Mastozytosis
โ€ข Myeloid Fibrosis
โ€ข MLL
โ€ข Thymic Cancer
โ€ข Glioblastoma
โ€ข AML
โ€ข Others

๐†๐ž๐จ๐ ๐ซ๐š๐ฉ๐ก๐ข๐œ ๐‹๐š๐ง๐๐ฌ๐œ๐š๐ฉ๐ž

โ€ข North America is projected to dominate the global market owing to increasing cancer cases and the booming biotechnological sector. Besides, the presence of key players with a global reach in the region further fuels the market growth.

โ€ข The shifting patterns and growing usage of apt technologies are projected to fuel the market demand in the European region. The therapy has garnered positive opinions from the Committee for Medicinal Products for Human Use (CHMP), owing to which the industry is expected to boost.

๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ:

๐”๐ง๐ฆ๐ž๐ญ ๐Œ๐ž๐๐ข๐œ๐š๐ฅ ๐๐ž๐ž๐: CAR T cell therapy addresses a significant unmet medical need for patients with certain types of cancer, particularly those who have relapsed or become refractory to conventional treatments such as chemotherapy and radiation therapy. The lack of effective treatment options for these patients drives demand for innovative therapies like CAR T cell therapy.

๐€๐๐ฏ๐š๐ง๐œ๐ž๐ฆ๐ž๐ง๐ญ๐ฌ ๐ข๐ง ๐๐ข๐จ๐ญ๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ: Recent advancements in biotechnology, particularly in gene editing and cell engineering techniques, have facilitated the development and commercialization of CAR T cell therapy. These technological advancements have improved the efficiency, safety, and scalability of CAR T cell manufacturing, making it more accessible to patients.

๐‚๐ฅ๐ข๐ง๐ข๐œ๐š๐ฅ ๐’๐ฎ๐œ๐œ๐ž๐ฌ๐ฌ: Clinical trials have demonstrated the remarkable efficacy of CAR T cell therapy in treating hematologic malignancies such as leukemia and lymphoma. Positive clinical outcomes, including high response rates and durable remissions, have generated considerable excitement and investor interest in the field, driving further research and development efforts.

๐๐ซ๐จ๐ฐ๐ฌ๐ž ๐Œ๐จ๐ซ๐ž ๐ƒ๐ž๐ญ๐š๐ข๐ฅ๐ฌ:


๐‡๐ž๐ฆ๐š๐ญ๐จ๐ฅ๐จ๐ ๐ข๐œ ๐Œ๐š๐ฅ๐ข๐ ๐ง๐š๐ง๐œ๐ข๐ž๐ฌ: CAR T cell therapy has shown significant promise in the treatment of hematologic malignancies, including acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), non-Hodgkin lymphoma (NHL), and multiple myeloma. These cancers are characterized by the expression of specific antigens that can be targeted by CAR T cells.

๐’๐จ๐ฅ๐ข๐ ๐“๐ฎ๐ฆ๐จ๐ซ๐ฌ: While initially developed for hematologic malignancies, CAR T cell therapy is being investigated for the treatment of solid tumors, including lung cancer, breast cancer, pancreatic cancer, and glioblastoma. Overcoming the challenges associated with solid tumors, such as tumor heterogeneity and immunosuppressive microenvironments, represents a significant opportunity for the expansion of CAR T cell therapy into new indications.

๐‚๐€๐‘-๐“ ๐‚๐ž๐ฅ๐ฅ ๐“๐ก๐ž๐ซ๐š๐ฉ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐‡๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ

โ€ข CD19/CD22 is the CAR-T cell therapy with the largest market share. It has shown remarkable clinical results in leukemia and lymphoma treatment, gaining regulatory approval and proving effective in achieving patient remission.

โ€ข DLBCL (Diffuse Large B-cell Lymphoma) is a prominent indication in the CAR-T cell therapy market, holding a significant market share. This fast-growing cancer of B-cell origin is a prevalent form of non-Hodgkin lymphoma affecting the lymphatic system.

โ€ข North America is set to lead the market, driven by rising cancer incidence and the growing biotechnology industry. The region's demand for cancer treatments is increasing accordingly.

๐Œ๐จ๐ซ๐ž ๐“๐ซ๐ž๐ง๐๐ข๐ง๐  ๐‹๐š๐ญ๐ž๐ฌ๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐›๐ฒ ๐๐จ๐ฅ๐š๐ซ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก:

๐•๐ข๐ฌ๐œ๐จ๐ฌ๐ฎ๐ฉ๐ฉ๐ฅ๐ž๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง ๐Œ๐š๐ซ๐ค๐ž๐ญ:

๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ'๐ฌ ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ:

๐„๐ฉ๐ข๐ฅ๐ž๐ฉ๐ฌ๐ฒ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ:

๐๐ฅ๐จ๐จ๐ ๐“๐ซ๐š๐ง๐ฌ๐Ÿ๐ฎ๐ฌ๐ข๐จ๐ง ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ:

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐”๐ฌ:

Polaris Market Research
Phone: +1-929-297-9727

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Car T Cell Therapy Market is Expected to Exhibit of 118,680.68 Million Massive Growth at 43.20% over Forecast Period 2024-2032 here

News-ID: 3489113 • Views: โ€ฆ

More Releases from Polaris Market Research & Consulting

Distributed Antenna System (DAS) Market: Insightful Analysis of the USD 14.92 Billion Revenue by 2030
Distributed Antenna System (DAS) Market: Insightful Analysis of the USD 14.92 Bi โ€ฆ
The global Distributed Antenna System (DAS) market has seen substantial growth and is expected to continue expanding at a robust rate. This growth is driven by increasing demand for enhanced cellular coverage, the proliferation of connected devices, and the ongoing expansion of wireless communication infrastructure. According to the research report published by Polaris Market Research, the global Distributed Antenna System (DAS) market was valued at USD 8.75 billion in 2021 andโ€ฆ
Management Decision Market on Track to Hit USD 13.91 Billion By 2030, Propelled by an Impressive CAGR of 13.2%
Management Decision Market on Track to Hit USD 13.91 Billion By 2030, Propelled โ€ฆ
The management decision market was valued at USD 4.90 billion in 2021 and is expected to rise to USD 13.91 billion by 2030. The market is expected to register a CAGR of 13.2% during the forecast period from 2022 to 2032. Various factors propelling the demand for management decisions include: โ— The management decision industry has experienced significant growth in recent decades, a trend bolstered by a range of factors. Notably,โ€ฆ
Razor Market Projected to Generate USD 16.85 Billion by 2032, with a CAGR of 3.30% from 2024 to 2032 | Polaris Market Research
Razor Market Projected to Generate USD 16.85 Billion by 2032, with a CAGR of 3.3 โ€ฆ
Global Razor Market size and share is currently valued at USD 12.6 billion in 2023 and is anticipated to generate an estimated revenue of USD 16.85 billion by 2032, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 3.30% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2024 - 2032 The razor market, an essential segment of the personal groomingโ€ฆ
Explosive Growth Forecasted: Private Tutoring Market to Reach USD 187.30 Billion by 2030
Explosive Growth Forecasted: Private Tutoring Market to Reach USD 187.30 Billion โ€ฆ
The private tutoring market size is projected to be valued at USD 92.30 billion in 2021 and is expected to rise to USD 187.30 billion by 2030. The market is expected to register a CAGR of 8.6% during the forecast period from 2022 to 2032. ๐•๐š๐ซ๐ข๐จ๐ฎ๐ฌ ๐Ÿ๐š๐œ๐ญ๐จ๐ซ๐ฌ ๐ฉ๐ซ๐จ๐ฉ๐ž๐ฅ๐ฅ๐ข๐ง๐  ๐ญ๐ก๐ž ๐๐ž๐ฆ๐š๐ง๐ ๐Ÿ๐จ๐ซ ๐ฉ๐ซ๐ข๐ฏ๐š๐ญ๐ž ๐ญ๐ฎ๐ญ๐จ๐ซ๐ข๐ง๐  ๐ข๐ง๐œ๐ฅ๐ฎ๐๐ž: Increased investment in private education and strategic alliances among major companies will aid market growth throughout theโ€ฆ

All 5 Releases

More Releases for CAR

Car Rental Services Market Forecast to 2028 Covid-19 Impact and Global Analysis โ€ฆ
Car rental services are a process of hiring/renting a car for a limited period from a rental company. Various companies like Uber Technologies, Europcar rent the vehicles for a short period ranging from few hours to weeks. The different types of cars rented by the company include Luxury Car, executive car, and economical car among others. Additionally, vehicle renting agencies also offer other products such as insurance, entertainment systems, andโ€ฆ
Central African Republic: Country Intelligence Report | Telecel, Orange CAR, Moo โ€ฆ
HTF Market Intelligence released a new research report of 36 pages on title 'Central African Republic: Country Intelligence Report' with detailed analysis, forecast and strategies. The market Study is segmented by key a region that is accelerating the marketization. The study is a perfect mix of qualitative and quantitative Market data collected and validated majorly through primary data and secondary sources. The study covers key regions that includes Centralโ€ฆ
Car Rentals Market Growth Strategies and Innovative Technology Transformation by โ€ฆ
Worldwide Market Reports has announced the addition of the "Car Rentals Market Report 2020-2027 Production, Sales And Consumption Status And Prospects Professional Research", The report classifies the global Car Rentals Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. The emergence of own-brand digital ordering platform has been trending in the global Car Rentals market. Car Rentals such asโ€ฆ
Luxury Car Leasing Market Competitors Analysis By German Rent A Car, ANI Technol โ€ฆ
 'Global Luxury Car Leasing Market Research Report' the report is complete with an elaborate research undertaken by prominent analysts and a detailed analysis of the global industry place. The Luxury Car Leasing report is fragmented in several features which include manufacturers, region, type, application, market status, market share, growth rate, future trends, market drivers, opportunities, challenges, emerging trends, risks, entry barriers, sales channels, and distributors which are again elaborated inโ€ฆ
Car Wash Market is Thriving Worldwide 2026 | Super Star Car Wash, Autobell Car W โ€ฆ
This Car Wash Market research report offers you an array of insights about Automotive industry and business solutions that will support to stay ahead of the competition. Systematic investment analysis is also underlined in this Car Wash Market report which forecasts impending opportunities for the market players.This market report is the outcome of persistent efforts lead by knowledgeable forecasters, innovative analysts and brilliant researchers who carries out detailed and diligentโ€ฆ
Car Rentals Market Growth 2020-2025: Sixt Rent A Car, Malkey Rent A Car, Casons โ€ฆ
Car Rentals Industry Description Wiseguyreports.Com Adds "Car Rentals -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2025" To Its Research Database The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Car Rentals by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chainโ€ฆ